15/11/2016 (Agence Europe) – On Tuesday 15 November, the European agency for judicial cooperation (Eurojust) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) published a joint report on new synthetic drugs – of which they counted 300 from 2013 to 2015. The report particularly shows that the member states found it difficult to confront the speed with which these drugs appeared on the European market. The report notes that the member states responded by means of health or consumer protection legislation, or by amending other legislation such as that on medicinal products. In the latter case, the report notes that it was difficult to launch judicial proceedings. The joint report can be consulted here: http://bit.ly/2fVJkrq . (SP)